Celgene Corp. buy geldnutzer
Start price
24.12.15
/
50%
€109.54
Target price
11.01.16
€133.95
Performance (%)
-15.45%
End price
11.01.16
€92.62
Summary
This prediction ended on 11.01.16 with a price of €92.62. The price of Celgene Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.45%. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by geldnutzer for this prediction
In the thread Celgene Corp. diskutieren
Auf zu Neuen Kursen
Diese Aktie gehört im Biotech-Sektor zu den Basis-Anlagen.
Hier wird es jetzt weiter nach oben gehen, 2016 kann kommen.
(Vom Mitglied beendet)